Cite
Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis.
MLA
Andrews, Martin J. I., et al. “Discovery of a Series of Imidazopyrazine Small Molecule Inhibitors of the Kinase MAPKAPK5, That Show Activity Using in Vitro and in Vivo Models of Rheumatoid Arthritis.” Bioorganic & Medicinal Chemistry Letters, vol. 22, no. 6, Mar. 2012, pp. 2266–70. EBSCOhost, https://doi.org/10.1016/j.bmcl.2012.01.077.
APA
Andrews, M. J. I., Andrew Clase, J., Bar, G., Tricarico, G., Edwards, P. J., Brys, R., Chambers, M., Schmidt, W., MacLeod, A., Hirst, K., Allen, V., Birault, V., Le, J., Harris, J., Self, A., Nash, K., & Dixon, G. (2012). Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters, 22(6), 2266–2270. https://doi.org/10.1016/j.bmcl.2012.01.077
Chicago
Andrews, Martin J.I., J. Andrew Clase, Gregory Bar, Giovanni Tricarico, Paul J. Edwards, Reginald Brys, Mark Chambers, et al. 2012. “Discovery of a Series of Imidazopyrazine Small Molecule Inhibitors of the Kinase MAPKAPK5, That Show Activity Using in Vitro and in Vivo Models of Rheumatoid Arthritis.” Bioorganic & Medicinal Chemistry Letters 22 (6): 2266–70. doi:10.1016/j.bmcl.2012.01.077.